Core Viewpoint - The company, Aihuilong (688575.SH), has recently received a medical device registration certificate from the Guangdong Provincial Drug Administration for its product, the Soluble Growth Stimulating Expression Gene 2 Protein Detection Kit (Chemiluminescence Method) and Chemiluminescence Immunoassay Analyzer [1] Group 1 - The product is aimed at enhancing diagnostic capabilities in the medical field [1] - The registration certificate signifies regulatory approval, which is crucial for market entry and commercialization [1] - This development may open new revenue streams for the company in the healthcare sector [1]